Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-12-031706
Filing Date
2012-06-01
Accepted
2012-06-01 17:05:22
Documents
1
Period of Report
2012-06-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3830
  Complete submission text file 0001209191-12-031706.txt   5115
Mailing Address
Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6165776000
VERTEX PHARMACEUTICALS INC / MA (Issuer) CIK: 0000875320 (see all company filings)

EIN.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY ST., ATTN: GENERAL COUNSEL CAMBRIDGE MA 02139
Business Address
Emmens Matthew (Reporting) CIK: 0001298332 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19319 | Film No.: 12884087